News tagged with 'Propulsid'

Johnson & Johnson attorneys will have their hands full over the next few weeks as two new trials began Monday over its withdrawn heartburn medication Propulsid. The cases, which will be heard in New Orleans and Napa County, California, are the first Propulsid claims in over a year to reach trial. The lawsuits were

A Mississippi Circuit Court judge has reduced a $100 million verdict in a case involving Johnson & Johnson's heartburn drug Propulsid. The former Propulsid users filed suit against the manufacturer of the drug, Janssen Pharmaceutica, a subsidiary of Johnson & Johnson, alleging that Propulsid caused their serious heart

Patients who took Propulsid, Janssen Pharmaceutica's heartburn drug banned in 2000 after it was linked to serious heart problems, are seeking retribution. If the results of the first case against the drug maker are any indication, Propulsid victims will succeed. A Mississippi jury recently awarded ten plaintiffs $100

In late September 2001, a Mississippi jury awarded ten plaintiffs $100 million in compensatory damages after they alleged that the heartburn drug Propulsid caused their serious heart rhythm disturbances. The defendant and manufacturer of Propulsid, Janssen Pharmaceutica, a subsidiary of Johnson & Johnson, said it woul

When Gage Stevens was born he brought joy into the lives of his parents. Unfortunately, their happiness was short lived. Gage was constantly irritable, so his parents took him to a doctor to determine the cause of his irritability. Dr. Susan Orenstein of Pittsburgh's Children's Hospital diagnosed Gage with acid refl

Italian doctors are still prescribing Propulsid, even though warning labels state that the drug may be extremely dangerous for many patients. In June 1998, the makers of Propulsid, Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, placed new warning labels on the drug, notifying doctors and patients of potentia

Many drug makers utilize warning labels to inform doctors about the possibility of dangerous side effects and drug interactions. Critics of this practice note that many warnings are buried deep within the so-called "package insert" and often come in very small print. These critics further claim that today's increasin

Propulsid, a heartburn drug manufactured by Janssen Pharmaceutica, a Johnson & Johnson Co. subsidiary, is now banned. The removal of Propulsid came too late for many patients and unfortunately many of those who died were children. Propulsid, approved in 1993 and withdrawn from the market in July 2000, was shown to inc